# Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Study · id `cardio:ct-nct05101005` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05101005](<https://clinicaltrials.gov/study/NCT05101005>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05101005

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT05101005. Randomized; no masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2023-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT05101005, source copy `cardio:ctgov-nct05101005-2021-10-29`, retrieved 2026-10-26)
- Planned start: 2021-10 (anticipated) (ClinicalTrials.gov record NCT05101005, source copy `cardio:ctgov-nct05101005-2021-10-29`, retrieved 2026-10-26)
- Primary completion: 2023-11 (anticipated) (ClinicalTrials.gov record NCT05101005, source copy `cardio:ctgov-nct05101005-2021-10-29`, retrieved 2026-10-26)
- Completion: 2023-11 (anticipated) (ClinicalTrials.gov record NCT05101005, source copy `cardio:ctgov-nct05101005-2021-10-29`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05101005-2021-10-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions
- Condition: Coronary Artery Disease
- Condition: Drug-coated Balloon
- Intervention (Device): Drug-Coated Balloon
- Intervention (Device): Sirolimus-Eluting Stent
- Lead sponsor: Lepu Medical Technology (Beijing) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Lepu Medical Technology (Beijing) Co., Ltd. (`cardio:org-lepu-medical-technology-beijing-co-ltd`)

## Provenance

Content hash: 443cb9eece69dcceed645f55a6b69fa1efad5315727bc60977c4fc1c64c55f7a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
